Provided by Tiger Fintech (Singapore) Pte. Ltd.

Precision Biosciences Inc

5.49
+0.36007.02%
Post-market: 5.490.00000.00%19:01 EDT
Volume:297.48K
Turnover:1.62M
Market Cap:60.87M
PE:-1.97
High:5.80
Open:5.17
Low:5.09
Close:5.13
Loading ...

Precision BioSciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
03 Jun

Precision Biosciences Price Target Maintained With a $60.00/Share by HC Wainwright & Co.

Dow Jones
·
21 May

Precision BioSciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Precision BioSciences Reports Sharp Revenue Decline in Q1 2025 with Less Than $0.1M from Previous $17.6M

Reuters
·
15 May

BRIEF-Precision Biosciences Q1 Income From Operations USD -22.112 Million

Reuters
·
15 May

Precision BioSciences Q1 EPS $(2.21) Misses $(1.72) Estimate, Sales $29.00K Miss $5.00M Estimate

Benzinga
·
15 May

Precision BioSciences, Inc. Q1 Net Income USD -20.565 Million

THOMSON REUTERS
·
15 May

Precision BioSciences Announces Acceleration of PBGENE-DMD Gene Editing Approach for Duchenne Muscular Dystrophy

Reuters
·
15 May

Precision BioSciences Inc. Highlights PBGENE-DMD at American Society of Gene and Cell Therapy Annual Meeting

Reuters
·
15 May

Precision BioSciences Inc expected to post a loss of $1.72 a share - Earnings Preview

Reuters
·
10 May

Press Release: Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025

Dow Jones
·
08 May

Precision BioSciences Announces Presentation of Initial Safety Data From the Phase 1 Eliminate-B Trial Evaluating Pbgene-Hbv at the 2025 European Association for the Study of the Liver Congress (Easl)

THOMSON REUTERS
·
07 May

Precision BioSciences Inc. to Present Multiple Gene Editing Programs at ASGCT Annual Meeting

Reuters
·
01 May

Precision BioSciences Announces Multiple Presentations for in Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (Asgct) Annual Meeting

THOMSON REUTERS
·
01 May

Precision BioSciences Announces Multiple Presentations for In Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Business Wire
·
01 May

Precision BioSciences (DTIL) Receives a Buy from H.C. Wainwright

TIPRANKS
·
01 May

BRIEF-Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Reuters
·
29 Apr

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
29 Apr

DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up

Zacks
·
16 Apr

Precision BioSciences Gets FDA Fast Track Label for PBGENE-HBV

MT Newswires Live
·
15 Apr